Cintas Corporation vs Oscar Health Inc — how do they compare? Cintas Corporation trades at $202.61 (market cap $79.86B), while Oscar Health Inc trades at $33.4 (market cap $10.22B). The key difference: Cintas Corporation is far larger — about 7.8× Oscar Health Inc's market cap, and Cintas Corporation pays a 1.03% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cintas Corporation for 125 Days and Oscar Health Inc for 15 Days on average.
| CTAS | OSCR | |
|---|---|---|
Market Cap | $79.86B | $10.22B |
Volume | 1,323,583 | 4,123,394 |
Sector | Industrials | Health |
52-Week High | $216.53 | $33.81 |
52-Week Low | $163.55 | $10.85 |
Typical Hold Time | 125 Days | 15 Days |
Enterprise Value | $82.33B | $6.57B |
Dividend Yield | 1.03% | — |
Signals from Pluang's Aura AI — not financial advice
Cintas (CTAS) trades at $202.25, up 2.57% today, reflecting strong momentum after recent earnings beats. The stock shows bullish technical signals, with price above key moving averages and support at $198. Fundamentally, Q1 2027 revenue reached $3.01 billion, a 10.9% YoY increase, with earnings per share of $1.39 beating estimates. The company raised fiscal 2027 guidance, signaling confidence in continued organic growth and margin expansion, supported by a robust business model in uniform rental and workplace services.
The outlook remains positive given upward earnings revisions and a consensus price target of $234.60, implying 16% upside. However, risks include elevated valuation multiples (P/E 39.67) and sensitivity to economic cycles affecting corporate spending. Analyst sentiment is mixed with 40% buy ratings, but institutional ownership trends and dividend growth underscore long-term stability. Execution on guidance and margin sustainability are key to maintaining premium valuation.
OSCR trades at $33.41, up 1.52% today, with a bullish technical signal and strong recent earnings beats in Q1 and Q2 2026. The stock shows robust revenue growth, with 2026 revenue projected at $15.3B and a return to profitability. Analyst sentiment is mixed but leans positive, with a consensus price target of $34.00. Recent news highlights market share gains and raised 2026 guidance, though the stock faces tests from rising medical costs.
The outlook is cautiously optimistic, driven by scalable growth in the ACA market and margin expansion opportunities. Key risks include medical cost pressures and competitive threats. Upside potential exists if the company executes on its 2029 EPS target of $4+, but investors should monitor profitability sustainability amid cost headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →